In new drug development process, one of the most important milestones for a drug candidate is to establish Proof of Concept (PoC) at early Phase II stage. Among many challenges in PoC clinical trial design and analysis, the application of multiplicity comparison procedures (MCP) is frequently discussed when multiple doses or drugs are included in one PoC study. In such discussion, one fundamental question of applying multiplicity adjustment is which error one should consider to control and at what level. Should it be the experiment-wise error or the compound-wise error? In this paper, the multiplicity issues in two cases of PoC studies are used as examples to discuss the concept of different types of error and the level of the error rate control. With a clear understanding of the type of error and error rate control, the debate of applications of the multiplicity adjustment procedures in the PoC studies can be reconciled.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.